rs17073

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000089.4(COL1A2):​c.541-129C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0918 in 926,898 control chromosomes in the GnomAD database, including 4,578 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.081 ( 618 hom., cov: 32)
Exomes 𝑓: 0.094 ( 3960 hom. )

Consequence

COL1A2
NM_000089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.224

Publications

1 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 7-94406121-C-T is Benign according to our data. Variant chr7-94406121-C-T is described in ClinVar as Benign. ClinVar VariationId is 1297451.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A2NM_000089.4 linkc.541-129C>T intron_variant Intron 11 of 51 ENST00000297268.11 NP_000080.2 P08123A0A0S2Z3H5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A2ENST00000297268.11 linkc.541-129C>T intron_variant Intron 11 of 51 1 NM_000089.4 ENSP00000297268.6 P08123

Frequencies

GnomAD3 genomes
AF:
0.0815
AC:
12397
AN:
152120
Hom.:
617
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0423
Gnomad AMI
AF:
0.0998
Gnomad AMR
AF:
0.0878
Gnomad ASJ
AF:
0.138
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0207
Gnomad FIN
AF:
0.0755
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.112
Gnomad OTH
AF:
0.0980
GnomAD4 exome
AF:
0.0938
AC:
72670
AN:
774660
Hom.:
3960
AF XY:
0.0911
AC XY:
36995
AN XY:
406014
show subpopulations
African (AFR)
AF:
0.0376
AC:
741
AN:
19720
American (AMR)
AF:
0.0710
AC:
2531
AN:
35658
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
2677
AN:
21258
East Asian (EAS)
AF:
0.0000302
AC:
1
AN:
33144
South Asian (SAS)
AF:
0.0267
AC:
1779
AN:
66564
European-Finnish (FIN)
AF:
0.0800
AC:
3354
AN:
41938
Middle Eastern (MID)
AF:
0.126
AC:
559
AN:
4432
European-Non Finnish (NFE)
AF:
0.112
AC:
57392
AN:
514132
Other (OTH)
AF:
0.0962
AC:
3636
AN:
37814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
3339
6677
10016
13354
16693
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1202
2404
3606
4808
6010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0814
AC:
12393
AN:
152238
Hom.:
618
Cov.:
32
AF XY:
0.0778
AC XY:
5790
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0422
AC:
1751
AN:
41536
American (AMR)
AF:
0.0875
AC:
1338
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.138
AC:
478
AN:
3468
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.0216
AC:
104
AN:
4824
European-Finnish (FIN)
AF:
0.0755
AC:
800
AN:
10602
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.112
AC:
7583
AN:
68002
Other (OTH)
AF:
0.0965
AC:
204
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
575
1150
1726
2301
2876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0828
Hom.:
284
Bravo
AF:
0.0823
Asia WGS
AF:
0.0150
AC:
51
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.7
DANN
Benign
0.58
PhyloP100
-0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17073; hg19: chr7-94035433; API